Earnings Alerts

Ackermans & Van Haaren Nv (ACKB) Earnings: FY Net Income Forecast Raised Above EU400 Million Amid Strong Q3 Performance

By November 22, 2024 No Comments
  • Ackermans has increased its full-year net income forecast to above €400 million.
  • The company previously expected net income to surpass €399.2 million, with a current estimate of €467.3 million.
  • In the third quarter, Ackermans reported net cash of €294.8 million, marking a 33% decrease quarter-over-quarter.
  • The company attributed continued outstanding performance in its core participations, such as DEME, Delen Private Bank, and Bank van Breda, for driving positive momentum into the third quarter.
  • Market analysts currently rate Ackermans with 5 buy ratings, 3 hold ratings, and no sell ratings.

A look at Ackermans & Van Haaren Nv Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth3
Resilience2
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

With a promising long-term outlook, Ackermans & Van Haaren NV seems to be in a strong position for growth and performance. Its Smartkarma Smart Scores indicate a solid momentum, showcasing a potential for continued positive stock performance. While the company’s dividend and resilience scores are more conservative, the overall value and growth scores suggest a stable and potentially lucrative investment opportunity.

Ackermans & Van Haaren NV, an industrial holding company with interests in various sectors like contracting, dredging, environmental services, and private equity investing, appears to have a balanced portfolio for sustained success. The combination of a strong momentum score and diverse range of holdings positions the company well for long-term growth potential and market stability.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars